Valtteri Kaasinen
MD, PhD, Professor of Neurology
valtteri.kaasinen@utu.fi |
Clinical Neurology; Movement Disorders; Parkinson's disease; Addictions; Neurotransmitters; Neuroimaging; PET; SPECT; Dopamine System
Movement disorders, neurotransmitters and addictions
Dr. Kaasinen is Professor of Neurology at the University of Turku, and Chief Physician at Neurocenter of Turku University Hospital.
He was appointed as Adjuct Professor of Neurology in 2011, received special competence in medical education in 2016, and was appointed as full Professor of Neurology in 2021.
Dr. Kaasinen is a clinical neurologist and a movement disorder specialist who received his medical degree from the University of Turku in 1996. This was followed by a PhD focusing on brain dopamine PET imaging of Parkinson's disease in 2000. He did his postdoctoral training in 2003-2004 in the University of Groningen, The Netherlands.
Since 2004, he has led a research group that focuses on function brain PET and SPECT neurotransmitter imaging in Parkinson's disease, other movement disorders and behavioral addictions. His group is involved in several project that aim to improve diagnostics and treatment of neurological movement disorders.
Main focus of research is brain function and dysfunction in relation to neurotransmitters, addictions and movement disorders.
Dr. Kaasinen has been involved in curriculum planning and implementation of neurology courses since 2013. He is a personal teacher mentor for medical students and has supervised of several PhD students.
- Aivojen vapaiden myy-opioidireseptorien määrä vaihtelee ihmisten välillä (2020)
- Duodecim
- Deep brain stimulation for monogenic Parkinson’s disease: a systematic review (2020)
- Journal of Neurology
- Deficits in monitoring self-produced speech in Parkinson's disease (2020)
- Clinical Neurophysiology
- Interindividual variability and lateralization of mu-opioid receptors in the human brain (2020)
- NeuroImage
- Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety (2020)
- Neuropsychopharmacology
- No Change in Prevalence of Impulse Control Disorder Behaviors in Parkinson's Disease During the Last Decade (2020)
- Movement Disorders
- No Change in the Age-Adjusted Incidence of Parkinson's Disease in Finland for More Than 25 Years (2020)
- Movement Disorders
- Parkinsonin taudin ei-motoristen oireiden hoito (2020)
- Duodecim
- Parkinsonin taudin lääkkeiden erityiskorvausoikeuden saajien määrän muutos vuosina 1996–2015 (2020)
- Lääkärilehti
- PET aivosairauksissa (2020)
- Duodecim
- Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2 (2020)
- FASEB Journal
- Sex-Dependent Improvement in Survival of Parkinson's Disease Patients (2020)
- Movement Disorders Clinical Practice
- The neurochemical substrates of habitual and goal-directed control (2020)
- Translational Psychiatry
- Uutta tietoa Parkinsonin taudin synnyn ja tupakoinnin välisistä yhteyksistä (2020)
- Duodecim
- Wilson's Disease in Finland: A Nationwide Population‐Based Study (2020)
- Movement Disorders
- Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study (2019)
- Translational Psychiatry
- Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism (2019)
- Clinical Neuropharmacology
- Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [I-123]FP-CIT SPECT (2019)
- Journal of the Neurological Sciences
- Gender-dependent improvement in the survival of Parkinson’s disease patients in Finland (2019)
- Movement Disorders
- Huntingtonin tauti (2019)
- Duodecim



